Business & Industry

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

Yuvraj — Fri, 21 Aug 2026 13:33:12 +0000

A planned $3.5 billion pharmaceutical manufacturing campus in Upper Macungie Township, Pennsylvania, has advanced through the local development process after the Upper Macungie Planning Commission recommended final subdivision and land development approval on August 19, 2026. Known as Project Kennedy, the development by Eli Lilly calls for a 797,432-square-foot manufacturing campus on approximately 150 acres […]

The post Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania first appeared on World Pharma Today.

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Yuvraj — Thu, 20 Aug 2026 07:22:24 +0000

Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world’s most widespread tropical diseases. Under the terms of the agreement, GSK obtains an exclusive, worldwide license from Chugai […]

The post Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351 first appeared on World Pharma Today.

Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical Development

Yuvraj — Wed, 19 Aug 2026 13:38:24 +0000

Lonza has announced the launch of its Rapid Media Prototyping Service (RaMP) — a solution designed to give biopharmaceutical companies faster access to custom liquid and powder media for screening, process confirmation, and early development. Delivering Speed and Flexibility in Early Development The new service enables the production of non-GMP powder batches ranging from 1 […]

The post Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical Development first appeared on World Pharma Today.

Sandoz Expands Global Pipeline with Multi-Product Biosimilar Agreement

Yuvraj — Mon, 17 Aug 2026 14:11:23 +0000

Sandoz has entered into a collaboration agreement with Shanghai Henlius Biotech to co-develop a series of new biosimilars across international markets. The milestone-based transaction carries a total consideration of up to $322m, including near-term payments of up to $100.5m associated with initial product candidates. Under the terms of this biosimilar collaboration, Henlius will oversee development […]

The post Sandoz Expands Global Pipeline with Multi-Product Biosimilar Agreement first appeared on World Pharma Today.

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Yuvraj — Thu, 13 Aug 2026 13:41:28 +0000

Global data analytics provider Axtria Inc. announced plans on August 13, 2026, to expand its Forward Deployed Engineering organization to 1,000 engineers by December 2026. This expansion creates the industry’s largest pharma AI engineering initiative, addressing growing customer demand to deploy, scale, and operationalize enterprise artificial intelligence across commercial, medical, and market access functions. The […]

The post Axtria Scales Forward Deployed Engineering Team to 1,000 Experts first appeared on World Pharma Today.

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Yuvraj — Thu, 13 Aug 2026 12:31:11 +0000

Following months of negotiations with industry stakeholders, the US Food and Drug Administration (FDA) has published its proposed commitment letter for the GDUFA IV program. Announced in the Federal Register on Monday alongside details for an upcoming public meeting, the proposal introduces strategic initiatives to promote domestic manufacturing, implement a modernized meeting structure, and reduce […]

The post FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement first appeared on World Pharma Today.

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

Yuvraj — Thu, 06 Aug 2026 12:04:34 +0000

CSPC Pharmaceutical and AstraZeneca have signed a joint venture contract to establish a new-generation production facility in Shijiazhuang, China. The collaboration focuses on the manufacturing and global supply of mutually agreed biologics drug substances, with capital contributions structured at a 51:49 equity ratio in favor of CSPC Pharmaceutical. The agreement remains subject to customary closing […]

The post CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture first appeared on World Pharma Today.

Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger

Yuvraj — Thu, 06 Aug 2026 11:56:27 +0000

Bristol Myers Squibb has expanded its ongoing strategic partnership with Schrödinger through a new agreement to deploy the agentic AI co-scientist platform, Bunsen, across its research operations. Building upon an established collaboration in which Bristol Myers Squibb already utilizes Schrödinger computational tools, this enterprise-wide integration is designed to help scientific teams evaluate drug discovery AI […]

The post Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger first appeared on World Pharma Today.

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Yuvraj — Sat, 01 Aug 2026 08:52:49 +0000

The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the first phase of a comprehensive end-to-end digital drug regulatory platform within the next 18 months. Designed as a single-window interface for the Indian pharmaceutical industry, the platform aims to streamline regulatory processes, enhance operational efficiency, increase transparency, and simplify compliance oversight across […]

The post CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months first appeared on World Pharma Today.

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

Yuvraj — Fri, 31 Jul 2026 11:43:16 +0000

The World Health Organization (WHO) has officially launched the first global framework intended to assist medicines regulators in advancing the development of greener pharmaceuticals while maintaining the highest standards of safety, quality, and efficacy. The document, titled “Towards a greener pharmaceuticals’ regulatory highway: a framework for regulators as enablers of decarbonization,” outlines how regulatory authorities […]

The post WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals first appeared on World Pharma Today.